1.
Khalaf DJ, Avilés CM, Azad AA, Sunderland K, Todenhöfer T, Eigl BJ, Finch D, Le L, Atwell A, Keith B, Kollmannsberger C, Chi KN. A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate. CUAJ [Internet]. 2017 Dec. 1 [cited 2024 Apr. 25];12(2):E47-52. Available from: https://cuaj.ca/index.php/journal/article/view/4600